Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

136.88
Delayed Data
As of Aug 12
 +0.08 / +0.06%
Today’s Change
73.32
Today|||52-Week Range
167.33
+18.85%
Year-to-Date
Biotech Bonanza - Second Half Outlook
Jul 28 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close136.61
Today’s open136.32
Day’s range135.02 - 139.40
Volume391,563
Average volume (3 months)778,609
Market cap$16.6B
Data as of 3:59pm ET, 08/12/2020

Growth & Valuation

Earnings growth (last year)-7.13%
Earnings growth (this year)+21.81%
Earnings growth (next 5 years)-73.99%
Revenue growth (last year)+193.36%
P/E ratioNM
Price/Sales57.26
Price/Book11.18

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Therapeutics...+0.98+1.37%
CTLTCatalent Inc-0.09-0.10%
GLPGGalapagos NV+4.57+2.46%
SRPTSarepta Therapeutics...-0.03-0.02%
Data as of 4:00pm ET, 08/12/2020

Financials

Next reporting dateOctober 29, 2020
EPS forecast (this quarter)-$1.60
Annual revenue (last year)$219.8M
Annual profit (last year)-$886.1M
Net profit margin-403.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts